Prolacta Bioscience
17
1
2
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
17.6%
3 terminated/withdrawn out of 17 trials
78.6%
-7.9% vs industry average
0%
0 trials in Phase 3/4
18%
2 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Human Milk Cream as a Caloric Supplement in Pre-Term Infants
Role: collaborator
Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants
Role: collaborator
Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC)
Role: lead
Dietary Supplement With and Without a Probiotic
Role: lead
Dietary Supplement With and Without a Probiotic and/or Antibiotic
Role: lead
Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation
Role: lead
Human Milk Fortification in Extremely Preterm Infants
Role: collaborator
Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology
Role: collaborator
Human Milk for Congenital Gastrointestinal Disorders
Role: collaborator
Safety Study of Human Milk Oligosaccharides in Healthy Adults
Role: lead
Evaluation of Prolact-Plus Human Milk Fortifier
Role: lead
A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea
Role: lead
Donor Human Milk in Young Children Receiving Bone Marrow Transplantation
Role: collaborator
Outpatient Exclusive Human Milk Diet for Single Infant With Complex Congenital Heart Disease
Role: collaborator
Human-derived Human Milk Fortifiers (H2MF), Gut Microbiota and Oxidative Stress in Premature Infants
Role: collaborator
Nutritional Content of Breast Milk From Mothers of Premies
Role: collaborator
Randomized Study of Human-Milk Based Nutrition Versus Formula in Premature Infants
Role: lead
All 17 trials loaded